Evidence map›Paper›PMID 32775265›Full record

ArticleGland surgery2020

Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.

Bei Pei, Tongyang Li, Qi Qian, Wenqiang Fan, Xiao He, Yulan Zhu, Lingyun Xu

Abstract read
In one paragraph

Article in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  8. Article
  9. Article
  10. Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p.Laboratory investigation; a journal of technical methods and pathology · 2022
    Article
  11. MicroRNAs as therapeutic targets in breast cancer metastasis.Drug delivery and translational research · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bei PeiChangzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.
Tongyang LiDalian Medical University, Dalian, China.
Qi QianChangzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.
Wenqiang FanChangzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.
Xiao HeChangzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.
Yulan ZhuChangzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.
Lingyun XuChangzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer metastasis is the main problem that affects the therapy and prognosis of breast cancer patients. Studies have indicated the role of microRNAs in breast cancer regulation, but the mechanisms are largely unknown.

methodsIn this study, we determined the expression of microRNA-30c-5p (miR-30c-5p) and coactosin-like protein 1 (

resultsThe results showed that the expression of miR-30c-5p decreased, while the expression of COTL1 increased in breast cancer tissues. The results of luciferase reporting gene assay showed that, COTL1 was the target of miR-30c-5p. After miR-30c-5p was upregulated, the expression of COTL1 was reduced, microfilament arrangement was in disorder, and cell migration ability was inhibited. After miR-30c-5p was downregulated, the expression of COTL1 was increased, and the cell migration ability was enhanced. COTL1 protein expression levels were significantly higher in cancer tissues with lymph node metastasis.

conclusionsThese findings indicate that miR-30c-5p/COTL1 pathway regulates breast cancer metastasis and can be used as a potential therapy target.

Indexed as

Breast cancercell migration abilitycoactosin-like protein 1 (COTL1)microfilamentmicroRNA-30c-5p (miR-30c-5p)

Identifiers

PMID32775265
PMCPMC7347814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.